Growing evidence suggests the crucial importance of TGF-β and EMT in LC progression [4,9,10,11], and therefore, a greater understanding of the molecular mechanisms surrounding them could provide key predictive markers and therapeutic targets for LC. Here, TGFB1 is linked to laryngotracheoesophageal cleft.